Abstract

User-Friendly MPS Platforms for Commercialization

Hiroshi Kimura, Associate Professor, Tokai University

Microphysiological system (MPS) has been widely studied as a novel method for estimating the effects and toxicities of drugs, providing an alternative to animal tests in drug discovery. In the EU and USA, various types of MPS are commercially available by many companies, and more recently, their practical application has been well promoted. Although MPS has been actively researched in Japan, there has been almost no practical MPS. Japan Agency for Medical Research and Development (AMED) has conducted an MPS development project to commercialize domestically produced MPS since 2017. Our research group has developed two types of MPS, Fluid3D-X® (TOK) and BioStellarTM Plate (Sumitomo Bakelite), for commercialization in collaboration with Japanese manufacturing companies in the project. Our proposed MPSs are expected to facilitate high-quality cell-based assays in drug discovery and biology due to their ease of use and high throughput. In this presentation, I present an overview of these MPS functions and provide examples of drug evaluation studies using the MPSs.